Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial - Ng, Siew C; Xu, Zhilu; Mak, Joyce Wing Yan; Yang, Keli; Liu, Qin; Zuo, Tao; Tang, Whitney; Lau, Louis; Lui, Rashid N; Wong, Sunny H; Tse, Yee Kit; Li, Amy Y L; et al. (Gut, 2022)
Keywords: Antibiotics; Body mass index; Cholesterol; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - therapy; Diet; Dietitians; Donors; Double-Blind Method; Double-blind studies; Drug dosages; enteric bacterial microflora; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Gut microbiota; Humans; Insulin; Intervention; Lifestyles; lipoprotein-cholesterol; Liver; Metabolic syndrome; Metagenomics; Microbiota; Obesity; Obesity - complications; Obesity - microbiology; Obesity - therapy; Probiotics; Transplantation; Treatment Outcome; Weight control; Hong Kong China; China; lipoprotein-cholesterol; enteric bacterial microflora; obesity